1. Neuronal Signaling
    JAK/STAT Signaling
    Protein Tyrosine Kinase/RTK
    PI3K/Akt/mTOR
    TGF-beta/Smad
    Stem Cell/Wnt
  2. Monoamine Oxidase
    EGFR
    Akt
    TGF-beta/Smad
  3. CCT365623 hydrochloride

CCT365623 hydrochloride 

Cat. No.: HY-124674A Purity: 98.11%
Handling Instructions

CCT365623 hydrochloride is an orally active lysyl oxidase (LOX) inhibitor, with an IC50 of 0.89 μM. CCT365623 hydrochloride suppresses EGFR (pY1068) and AKT phosphorylation driven by EGF. CCT365623 hydrochloride is extremely well tolerated, and has good pharmacokinetic properties.

For research use only. We do not sell to patients.

CCT365623 hydrochloride Chemical Structure

CCT365623 hydrochloride Chemical Structure

CAS No. : 2126136-98-7

Size Price Stock Quantity
1 mg USD 290 In-stock
Estimated Time of Arrival: December 31
5 mg USD 850 In-stock
Estimated Time of Arrival: December 31
10 mg USD 1350 In-stock
Estimated Time of Arrival: December 31
25 mg USD 2650 In-stock
Estimated Time of Arrival: December 31
50 mg USD 3950 In-stock
Estimated Time of Arrival: December 31
100 mg USD 5650 In-stock
Estimated Time of Arrival: December 31
200 mg   Get quote  
500 mg   Get quote  

* Please select Quantity before adding items.

Customer Review

Based on 1 publication(s) in Google Scholar

Top Publications Citing Use of Products

View All Monoamine Oxidase Isoform Specific Products:

View All EGFR Isoform Specific Products:

View All Akt Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

CCT365623 hydrochloride is an orally active lysyl oxidase (LOX) inhibitor, with an IC50 of 0.89 μM. CCT365623 hydrochloride suppresses EGFR (pY1068) and AKT phosphorylation driven by EGF. CCT365623 hydrochloride is extremely well tolerated, and has good pharmacokinetic properties[1].

IC50 & Target

IC50: 0.89 μM (LOX)[1].

In Vitro

CCT365623 inhibits LOX at ~5 μM in the biosensor system[1].
CCT365623 (0-40 μM) concentration-dependently decreases the protein levels of surface EGFR[1].
CCT365623 (5 μM) decreases the protein levels of pY1068 EGFR, pAKT and MATN2, and increases the protein levels of pSMAD2[1].
CCT365623 disrupts HTRA1 multimerization, activates TGFβ1 signalling, suppresses MATN2 expression, suppresses EGFR surface retention, and suppresses EGFR signalling[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: MDA-MB-231 cells.
Concentration: 0-40 μM.
Incubation Time: 24 hours
Result: Significantly decreased the protein levels of surface EGFR, pY1068 EGFR, pAKT and MATN2.
Increased the protein levels of pSMAD2.
In Vivo

CCT365623 displays good stability in mouse liver microsomes and does not inhibit the cardiac potassium channel hERG[1].
CCT365623 (70 mg/kg, oral gavage per day) significantly delays the development of the primary tumors and also suppresses metastatic lung burden in the animals. CCT365623 disrupts EGFR cell surface retention and delays the growth of primary and metastatic tumor cell[1].
CCT365623 exhibits a T1/2PO of 0.6 h and F% (oral bioavailability) of 45%[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Mouse model of spontaneous breast cancer that metastasizes to the lungs (70 days old)[1].
Dosage: 70 mg/kg.
Administration: Oral gavage per day for about 3 weeks.
Result: Significantly reduced MATN2 protein levels in both the primary and metastatic lung tumors and this is accompanied by the loss of EGFR from the plasma membranes of the cells in both the primary and metastatic tumors.
Molecular Weight

443.99

Formula

C18H18ClNO4S3

CAS No.
SMILES

NCC1=CC=C(S(=O)(C2=CC(C3=CC=CC=C3)=CC(S(=O)(C)=O)=C2)=O)S1.Cl

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

Solvent & Solubility
In Vitro: 

DMSO : 250 mg/mL (563.08 mM; Need ultrasonic)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.2523 mL 11.2615 mL 22.5230 mL
5 mM 0.4505 mL 2.2523 mL 4.5046 mL
10 mM 0.2252 mL 1.1262 mL 2.2523 mL
*Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one:  10% DMSO    40% PEG300    5% Tween-80    45% saline

    Solubility: ≥ 2.08 mg/mL (4.68 mM); Clear solution

  • 2.

    Add each solvent one by one:  10% DMSO    90% (20% SBE-β-CD in saline)

    Solubility: ≥ 2.08 mg/mL (4.68 mM); Clear solution

  • 3.

    Add each solvent one by one:  10% DMSO    90% corn oil

    Solubility: ≥ 2.08 mg/mL (4.68 mM); Clear solution

*All of the co-solvents are available by MCE.
Purity & Documentation

Purity: 98.11%

References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email address *

Phone number *

 

Organization name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
CCT365623 hydrochloride
Cat. No.:
HY-124674A
Quantity:
MCE Japan Authorized Agent: